NFA
IONS icon

Nationwide Fund Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Nationwide Fund Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-76,457
Closed -$3.88M – 1015
2017
Q3 		$3.88M Hold
76,457
– – 0.02% 1128
2017
Q2 		$3.89M Buy
76,457
+57,952
+313% +$2.7M 0.02% 1136
2017
Q1 		$744K Hold
18,505
– – ﹤0.01% 1928
2016
Q4 		$885K Sell
18,505
-2,380
-11% -$94.2K ﹤0.01% 1851
2016
Q3 		$765K Buy
+20,885
New +$653K ﹤0.01% 1943
2015
Q3 		– Sell
-15,030
Closed -$865K – 3290
2015
Q2 		$865K Sell
15,030
-90,073
-86% -$5.73M ﹤0.01% 1939
2015
Q1 		$6.69M Sell
105,103
-3,022
-3% -$205K 0.03% 832
2014
Q4 		$6.68M Sell
108,125
-187
-0.2% -$9.23K 0.03% 781
2014
Q3 		$4.21M Buy
108,312
+283
+0.3% +$10K 0.02% 1039
2014
Q2 		$3.72M Buy
108,029
+17,404
+19% +$548K 0.02% 1148
2014
Q1 		$3.92M Sell
90,625
-32,904
-27% -$1.59M 0.02% 1000
2013
Q4 		$4.92M Sell
123,529
-2,425
-2% -$86.4K 0.02% 962
2013
Q3 		$4.73M Sell
125,954
-44,442
-26% -$1.33M 0.02% 942
2013
Q2 		$4.58M Buy
+170,396
New +$3.62M 0.02% 849

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Nationwide Fund Advisors's IONS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Ionis Pharmaceuticals (IONS) in Q4 2017, closing a stake of 76,457 shares — an estimated $3.88M sold.

Nationwide Fund Advisors first reported a position in IONS in Q2 2013 and held it in 14 quarters. The position peaked at $6.69M in Q1 2015. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Ionis Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 76,457 Ionis Pharmaceuticals shares in Q4 2017, an estimated $3.88M.
  • Nationwide Fund Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's Ionis Pharmaceuticals position peaked at $6.69M in Q1 2015.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.